Original language | English |
---|---|
Pages (from-to) | 289-292 |
Number of pages | 4 |
Journal | Nature Metabolism |
Volume | 3 |
Issue number | 3 |
DOIs |
|
Publication status | Published - Mar 2021 |
Consequences of the COVID-19 pandemic for patients with metabolic diseases
Stefan R. Bornstein*, Francesco Rubino, Barbara Ludwig, Hannes Rietzsch, Peter E.H. Schwarz, Roman N. Rodionov, Kamlesh Khunti, David Hopkins, Andreas L. Birkenfeld, Bernhard Boehm, Stephanie Amiel, Richard I.G. Holt, Jay S. Skyler, J. Hans DeVries, Eric Renard, Robert H. Eckel, Paul Zimmet, K. G. Alberti, Bruno Geloneze, Juliana C. Chan
*Corresponding author for this work
- University Hospital Carl Gustav Carus
- Universitatsspital Zurich
- German Center for Diabetes Research
- TU Dresden
- University of Leicester
- St Thomas' Hospital
- University Hospital Tübingen
- University of Tuebingen
- TAN TOCK SENG HOSPITAL
- Nanyang Technological University
- University of Southampton, School of Medicine
- University of Miami
- University of Amsterdam
- Profil Institute for Metabolic Research
- CHRU Montpellier
- University of Colorado
- Monash Medical School
- Imperial College London
- UNICAMP
- Chinese University of Hong Kong
- University of Yaoundé
- Nile University of Nigeria
- India Diabetes Research Foundation
- Baqai Medical University
- Dubai Health Authority
- Agostino Gemelli University Polyclinic
- Catholic University of Sacred Heart Rome
Research output: Contribution to journal › Comment/debate › peer-review
35
Citations
(Scopus)